Rodman David Malcom sold MLYS
January 13, 2026 · Form 4 insider transaction
Rodman David Malcom sold 7,709 shares of Mineralys Therapeutics, Inc. at $32.75 per share, a transaction worth $252.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,709
Price
$32.75
Total value
$252.5K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 13, 2026
Filing dateJanuary 15, 2026
Shares owned after61,804
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.